Journal: Oncotarget
Article Title: SMAR1 inhibits Wnt/β-catenin signaling and prevents colorectal cancer progression
doi: 10.18632/oncotarget.25093
Figure Lengend Snippet: FACS analysis of pEGFP1-β-catenin GFP expression ( n = 3, SD) after; ( A ) Co-transfection with FLAG-vector or FLAG-SMAR1, and ( B ) Treatment with 200 ng/mL rh Wnt3a ligand. ( C ) ChIP showing occupancy of SMAR1, HDAC5 and H3K9 Ac (mean ± SD, n = 3) after Wnt3a CM stimulation. ( D ) ChIP showing occupancy of SMAR1, HDAC5 and H3K9 Ac (mean ± SD, n = 3) after SMAR1 overexpression or knockdown. ( E ) ChIP showing occupancy of HDAC5 (mean ± SD, n = 3) after si-HDAC5 knockdown in HCT116 cells. ( F ) Expression of β-catenin after knockdown with 2μg si-HDAC5 plasmid. ( G ) Immunoprecipitation of SMAR1 with HDAC5. ( H ) Immunoprecipitation of HDAC5 with various truncations of SMAR1. ( I ) Immunoprecipitation of HDAC5 with SMAR1 after Wnt3a CM stimulation.
Article Snippet: For flow cytometry analysis HCT116 cells were trypsinized using Trypsin-EDTA (Gibco) and washed thrice with PBS buffer.
Techniques: Expressing, Cotransfection, Plasmid Preparation, Over Expression, Knockdown, Immunoprecipitation